
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vertex Pharmaceuticals (United Kingdom), United Kingdom, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
59%
Total
Publications
282
Total Open
Publications
165
Total
Citations
21K
Open Access
Percentage
59%
Total
Publications
282
Total Open
Publications
165
Total
Citations
21K
Breakdown
Publisher Open
18%
Both
28%
Other Platform Open
13%
Closed
41%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 39%
50
Hybrid 30%
39
No Guarantees 31%
40
Other Platform Open
Domain 68%
78
Institution 53%
60
Other Internet 18%
21
Preprint 11%
12
Public 6%
7
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 78 |
doaj.org OAI-PMH Repository | Institution | 22 |
DOI | Other Internet | 20 |
University of Oxford | Institution | 11 |
University of Edinburgh | Institution | 8 |
Figshare | Public | 8 |
University of Bristol | Institution | 7 |
bioRxiv | Preprint | 7 |
Europe PMC | Domain | 6 |
University of Nottingham | Institution | 5 |